All Online

1 - 12 of 40 results

Refine

Active filters

Coronavirus Disease (COVID-19)
0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how seropositivity levels can vary after vaccination and which patients would make good candidates for monoclonal antibodies (mAbs). You’ll also hear the latest clinical trials data on the efficacy of mAbs.


1 CME CREDIT

COVID-19 Panel Discussion: February 2021

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


0.5 CME CREDIT

Join us for the first COVID-19 Pulse session of 2021! In the twenty-fourth episode of Pri-Med’s web series on COVID-19, faculty will walk through the Advisory Committee on Immunization Practices (ACIP) guidelines for COVID-19 vaccine prioritization as well as the newest data on these vaccines. This session will discuss the emerging SARS-CoV-2 variants and their potential implications. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.


physician performing medical exam to elder patient sitting with mask on
1 CME CREDIT

This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


0.5 CME CREDIT

Join us for the final COVID-19 Pulse session of 2020! In the twenty-third episode of Pri-Med’s web series on COVID-19, faculty revisit the discussion of monoclonal antibodies, with a more in-depth look at the recent data and recommendations on monoclonal antibody use in COVID-19. Our learners also continue to have many questions about the relationship between COVID-19 and thrombotic complications. This session will discuss those questions as well as prophylaxis and treatment for venous thromboembolism in patients with COVID-19. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions, including those about recent vaccine updates. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.


1 CME CREDIT

This presentation will review the various effects that COVID-19 may have on the cardiovascular system, with a focus on acute cardiac injury, myocarditis, and arrhythmias.


0.5 CME CREDIT

In the twenty-fifth episode of Pri-Med’s web series on COVID-19, faculty will approach the emerging and concerning concept of “long-haul” COVID-19. Additionally, this session will discuss postural orthostatic tachycardia syndrome (POTS) and the mechanisms connecting SARS-CoV-2 infection to POTS. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 02/09/2021 and they are subject to change as new information is published.


bottle spilling white pills on flat surface
1 CME CREDIT

New Drugs for the PCP: What You Need to Know

1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology

Keeping up with the many new drugs approved for use each year is a constant challenge. However only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk provides a balanced evaluation of these important novel drugs, and will address efficacy, side effects, cost, and the impact on primary care practice. In addition, we will discuss at length the efficacy and safety of the COVID vaccines available in the U.S. through Emergency Use Authorization.


pediatric physician flexing with young patient and mother in the back
1 CME CREDIT

Hot Topics in Pediatric Infectious Diseases

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

Dr. Deborah Lehman will review pediatric infectious disease hot topics for the general practitioner. Learners will hear updates on the COVID-19 pandemic, measles and the state of vaccine hesitancy.


1 CME CREDIT

Fight COVID-19 in Outpatient Settings With Neutralizing mAbs

1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology

Neutralizing monoclonal antibodies (mAbs) first received emergency use authorization (EUA) in November 2020 for treating at-risk patients with COVID-19--and the field has continued to evolve ever since. This presentation provides an update in the latest evidence showing reduced severe illness and hospitalization in patients treated with neutralizing mAbs. The expert presenters will explain the science and practical issues of using mAbs to treat patients with COVID-19 in outpatient and skilled nursing facility settings while also answering your questions from their multidisciplinary perspectives. This educational activity includes: • Best practices for identifying appropriate patients for mAb infusions and connecting these patients with infusion therapy • Overview of clinical trial data for efficacy and safety of treatment with neutralizing mAbs alone and in combination with other mAbs • Frontline stories of establishing mAbs infusion programs, including preparing, administering, monitoring, and reporting • Discussion of issues identified through analysis of responses to a survey conducted with Pri-Med learners